May 23, 2016 17:29 pm UTC| Business
Lima, Peru, May 23, 2016 -- Camposol S.A. (the "Company") announced today the results of its offer to exchange Existing Notes for New Notes announced on April 11, 2016 (the "Exchange Offer"). The Company received tenders...
California Life Sciences Association Hails Progress on Important Patient Protection Measure
May 23, 2016 16:19 pm UTC| Business
SACRAMENTO, Calif., May 23, 2016 -- California Life Sciences Association (CLSA), the nation's largest statewide life sciences public policy and business solutions organization representing over 750 of California's life...
SOITEC : SOITEC ANNOUNCES WITHDRAWAL OF SILICON GENESIS' PATENT LAWSUIT
May 23, 2016 16:15 pm UTC| Business
BERNIN (GRENOBLE), France, May 23, 2016 -- Soitec(Euronext), aworld leader in manufacturing semiconductor materialsfor the electronics industry, today announced that on May 18, 2016, Silicon Genesis Corporation (SiGen)...
:DentalPlans' Eye Care Tips for Healthy Vision Month
May 23, 2016 13:25 pm UTC| Business
PLANTATION, Fla., May 23, 2016 -- Are you sure that your eyes are as healthy as they should be? Many eye ailments that can cause blindness have no symptoms in their earliest stages. To protect your vision now and into the...
Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
May 23, 2016 12:20 pm UTC| Business
PARIS, France, May 23, 2016 -- Sanofi Chief Executive Officer Olivier Brandicourt, MD, announced today a number of changes to the company's Executive Committee, supporting Sanofi's recently announced 2020 Strategic...
May 23, 2016 12:18 pm UTC| Business
The briefing documents posted on FDA's website include results from the two Phase III trials with the lixisenatide/Lantus(r) combination, not previously published US regulatory decisions on lixisenatide and the...
May 23, 2016 11:16 am UTC| Business
Company Announcement DARZALEX (daratumumab) receives European conditional marketing authorization for heavily pre-treated or double refractory multiple myeloma First CD38 monoclonal antibody approved in...